Biologically important modes of polypeptide assembly
Biologically important modes of polypeptide assembly
批准号:
10625307
负责人:
SAMUEL H. GELLMAN
金额:
$36.21万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2024-05-31
关键词:
AddressAdoptedAdoptionAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAmino Acid SequenceAmyloidAmyloid FibrilsAmyloid beta-Protein PrecursorAreaBiological ModelsBiological ProcessBiologyCell Surface ReceptorsCell membraneCell physiologyCellsCollaborationsComplexCryoelectron MicroscopyCrystallizationCrystallographyDataDepositionDimensionsDiseaseFamilyFoundationsFutureGenerationsGeometryGoalsHealthHumanHydrophobic InteractionsHydrophobicityImmunologic ReceptorsLearningLinkLipid BilayersLiquid substanceMediatingMembraneMethodsMicro Electron DiffractionModelingMolecular ConformationPathogenicityPathologicPeptidesPhaseProtein FamilyProtein RegionProteinsReceptor ActivationReceptor Protein-Tyrosine KinasesResearchResolutionRoleSAP-A ProteinSignal TransductionStructureSystemT-Cell ReceptorTYROBP geneTechniquesTestingWorkX ray diffraction analysisalpha helixamyloid formationbeta pleated sheetchemical synthesisdesigndimerfused in sarcomahuman diseasein vivointerestpeptide chemical synthesispolypeptideprogramsprotein aminoacid sequenceprotein structurereceptorsolid state nuclear magnetic resonancestereochemistrysynthetic peptidetransmission process
中文摘要
总结
我们希望阐明多肽组装的模式,这对生物学的重要性,
功能和与人类疾病相关,但难以通过标准
实验方法。在每一种情况下,我们都希望了解非共价力,
是装配模式的基础。由于不同类型的装配,
研究中,我们采用的实验方法是可变的。
一个目标是表征通过单次跨膜形成的四级结构
(SPTM)α-螺旋,是细胞表面受体的组成部分,如受体酪氨酸
激酶(RTK)和活化免疫受体。这些受体形成寡聚体,
低聚物几何结构的重排传递信号。晶体学数据可在
仅针对免疫受体组分DAP 12的SPTM α-螺旋。没有高分辨率
SPTM α-螺旋组装体替代几何结构的结构信息,
与不同的受体激活状态有关。我们将外消旋结晶
和微电子衍射(通过合作)来应对这一结构挑战,我们正在
探索蛋白质为基础的“picodisks”作为SPTM α-螺旋组装的宿主。
第二个目标是了解序列、组成和维度如何影响
淀粉样状态多肽的稳定性。β-片层丰富的结构是常见的
疾病相关的淀粉样蛋白原纤维不同于三级和四级结构,
在可溶性蛋白质中发现。通常用于阐明序列稳定性的技术
可溶性蛋白质之间的关系不容易应用于淀粉样纤维;因此,我们
开发淀粉样蛋白状态的可溶性模型系统,我们将利用它来问
淀粉样蛋白状态稳定性的基本问题。
第三个目标是了解导致液-液相分离的力
(LLPS)由FUS(“融合在肉瘤中”)家族中的蛋白质介导。松散的联系
在富含蛋白质的液相中多肽链之间的相互作用还没有很好地理解。等
相可以转变为淀粉样蛋白组装,这在我们的大脑中形成了强烈的联系。
第二和第三个目标。这些更有序的组装与疾病有关,
人症我们试图用合成肽模拟FUS家族蛋白的LLPS,以便进行
对最近提出的机制进行了深入的测试,并评估了氨基酸序列的作用
和立体化学的LLPS和过渡到更有序和致病性组装。
英文摘要
SUMMARY
We want to elucidate modes of polypeptide assembly that are important for biological
function and associated with human disease but are difficult to characterize via standard
experimental approaches. In each case, we wish to understand the non-covalent forces that
underlie the assembly mode. Because of differences among the types of assembly we are
studying, the experimental approaches we adopt are variable.
One goal is to characterize quaternary structures formed by single-pass transmembrane
(SPTM) α-helices that are constituents of cell-surface receptors, such as receptor tyrosine
kinases (RTKs) and activating immune receptors. These receptors form oligomers, and
rearrangement of oligomer geometry transmits the signal. Crystallographic data are available in
only for the SPTM α-helix of immune receptor component DAP12. There is no high-resolution
structural information for alternative geometries of SPTM α-helix assemblies that are thought to
be associated with different receptor activation states. We are applying racemic crystallization
and micro-electron diffraction (via collaboration) to this structural challenge, and we are
exploring protein-based “picodiscs” as hosts for SPTM α-helix assemblies.
A second goal is to understand how sequence, composition and dimensions influence
stability of polypeptides in the amyloid state. The β-sheet-rich structures that are common to
disease-associated amyloid fibrils are distinct from tertiary and quaternary structures commonly
found among soluble proteins. The techniques commonly used to elucidate sequence-stability
relationships among soluble proteins are not readily applied to amyloid fibrils; therefore, we are
developing a soluble model system for the amyloid state, which we will exploit to ask
fundamental questions about amyloid state stability.
The third goal is to understand the forces that lead to liquid-liquid phase separation
(LLPS) mediated by proteins in the FUS (“fused in sarcoma”) family. The loose associations
between polypeptide chains in the protein-rich liquid phase are not well understood. Such
phases can transition to amyloid-like assemblies, which forms a strong connection between our
second and third goals. These more ordered assemblies are associated with illnesses such as
ALS. We seek to model LLPS of FUS family proteins with synthetic peptides in order to conduct
incisive tests of recent mechanistic proposals and to evaluate the role of amino acid sequence
and stereochemistry in LLPS and the transition to more ordered and pathogenic assemblies.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/anie.201506448
发表时间:
2015-11-23
期刊:
Angewandte Chemie (International ed. in English)
影响因子:
--
作者:
[Kung VM, Cornilescu G, Gellman SH]
通讯作者:
Gellman SH
DOI:
10.1021/ja8099294
发表时间:
2009-07-29
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Giuliano MW, Horne WS, Gellman SH]
通讯作者:
Gellman SH
DOI:
10.1021/ja103543s
发表时间:
2010-09-08
期刊:
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子:
15
作者:
[Price, Joshua L., Horne, W. Seth, Gellman, Samuel H.]
通讯作者:
Gellman, Samuel H.
DOI:
10.1016/b978-0-12-394292-0.00019-9
发表时间:
2013
期刊:
METHODS IN ENZYMOLOGY
影响因子:
--
作者:
[Johnson, Lisa M., Gellman, Samuel H.]
通讯作者:
Gellman, Samuel H.
Reinvestigation of the proposed folding and self-association of the Neuropeptide Head Activator.
重新研究神经肽头激活剂的拟议折叠和自缔合。
DOI:
10.1110/ps.0232103
发表时间:
2003
期刊:
Protein science : a publication of the Protein Society.
影响因子:
--
作者:
[Lai,JonathanR, Gellman,SamuelH]
通讯作者:
Gellman,SamuelH
共 31 条
Polymeric Agents for the Treatment of Clostridium difficile Infections
-
批准号:9186498
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2015
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Polymeric Agents for the Treatment of Clostridium difficile Infections
-
批准号:9021375
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2015
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8041852
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Nylon-3 Copolymers as Synthetic Cell-Adhesive Moieties for Tissue Engineering
-
批准号:8240031
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and Analysis of Random Copolymers with Antimicrobial Activity
-
批准号:9196509
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8708892
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8301533
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8513354
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Nylon-3 Copolymers as Synthetic Cell-Adhesive Moieties for Tissue Engineering
-
批准号:8090829
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Determinants of Fold Stability in Proteins and Analogues
-
批准号:7926143
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2009
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
2010 Chemistry and Biology of Peptides Gordon Research Conference
-
批准号:7804208
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
MALDI TOF/TOF Mass Spectrometer
-
批准号:7388564
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2008
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
VILLIN HEADPIECE SUBDOMAIN (VHP) STUDY
-
批准号:7598694
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
STUDIES ON BETA-AMINOACID OLIGOMERS
-
批准号:7598802
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
TRAINING IN THE USE OF BRUKER AND VARIAN SPECTROMETERS AND NMR
-
批准号:7598726
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
ROLE OF GLYCOPROTEIN B IN HCMV INFECTION
-
批准号:7598725
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: HEART
-
批准号:7166303
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: GLAUCOMA
-
批准号:7166299
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: CMV, HERPES, BACTERIAL PROTEINS
-
批准号:7166300
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Acquisition of Peptide Synthesizer for Core Facility
-
批准号:6876442
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
海外基金